251 related articles for article (PubMed ID: 24608427)
21. MiR-125 inhibited cervical cancer progression by regulating VEGF and PI3K/AKT signaling pathway.
Fu K; Zhang L; Liu R; Shi Q; Li X; Wang M
World J Surg Oncol; 2020 May; 18(1):115. PubMed ID: 32473637
[TBL] [Abstract][Full Text] [Related]
22. MiR-144-3p: a novel tumor suppressor targeting MAPK6 in cervical cancer.
Wu J; Zhao Y; Li F; Qiao B
J Physiol Biochem; 2019 Jun; 75(2):143-152. PubMed ID: 31016619
[TBL] [Abstract][Full Text] [Related]
23. Hsa_circ_0031288/hsa-miR-139-3p/Bcl-6 regulatory feedback circuit influences the invasion and migration of cervical cancer HeLa cells.
Xu YJ; Yu H; Liu GX
J Cell Biochem; 2020 Oct; 121(10):4251-4260. PubMed ID: 32277518
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma.
Cui L; Zhou H; Zhao H; Zhou Y; Xu R; Xu X; Zheng L; Xue Z; Xia W; Zhang B; Ding T; Cao Y; Tian Z; Shi Q; He X
BMC Cancer; 2012 Nov; 12():546. PubMed ID: 23173671
[TBL] [Abstract][Full Text] [Related]
25. miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6.
Xu J; Wan X; Chen X; Fang Y; Cheng X; Xie X; Lu W
Sci Rep; 2016 Jul; 6():28968. PubMed ID: 27364926
[TBL] [Abstract][Full Text] [Related]
26. The STAT3-miR-223-TGFBR3/HMGCS1 axis modulates the progression of cervical carcinoma.
Zhang J; Jiang M; Qian L; Lin X; Song W; Gao Y; Zhou Y
Mol Oncol; 2020 Sep; 14(9):2313-2331. PubMed ID: 32491253
[TBL] [Abstract][Full Text] [Related]
27. miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.
Zhao Y; Wang Y; Xing G
Biomed Pharmacother; 2018 Oct; 106():1650-1660. PubMed ID: 30119241
[TBL] [Abstract][Full Text] [Related]
28. Genetic and Methylation-Induced Loss of miR-181a2/181b2 within chr9q33.3 Facilitates Tumor Growth of Cervical Cancer through the PIK3R3/Akt/FoxO Signaling Pathway.
Mei Q; Li X; Zhang K; Wu Z; Li X; Meng Y; Guo M; Luo G; Fu X; Han W
Clin Cancer Res; 2017 Jan; 23(2):575-586. PubMed ID: 27503199
[TBL] [Abstract][Full Text] [Related]
29. miR-133a inhibits cervical cancer growth by targeting EGFR.
Song X; Shi B; Huang K; Zhang W
Oncol Rep; 2015 Sep; 34(3):1573-80. PubMed ID: 26134491
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q
Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-101-5p inhibits the growth and metastasis of cervical cancer cell by inhibiting CXCL6.
Shen W; Xie XY; Liu MR; Wang LL
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1957-1968. PubMed ID: 30915738
[TBL] [Abstract][Full Text] [Related]
32. MiR-337-3p suppresses proliferation of epithelial ovarian cancer by targeting PIK3CA and PIK3CB.
Zhang Z; Zhang L; Wang B; Wei R; Wang Y; Wan J; Zhang C; Zhao L; Zhu X; Zhang Y; Chu C; Guo Q; Yin X; Li X
Cancer Lett; 2020 Jan; 469():54-67. PubMed ID: 31629932
[TBL] [Abstract][Full Text] [Related]
33. MiR-22-3p Regulates Cell Proliferation and Inhibits Cell Apoptosis through Targeting the eIF4EBP3 Gene in Human Cervical Squamous Carcinoma Cells.
Lv KT; Liu Z; Feng J; Zhao W; Hao T; Ding WY; Chu JP; Gao LJ
Int J Med Sci; 2018; 15(2):142-152. PubMed ID: 29333098
[No Abstract] [Full Text] [Related]
34. microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4.
Li J; Hu L; Tian C; Lu F; Wu J; Liu L
BMC Mol Biol; 2015 Dec; 16():24. PubMed ID: 26715362
[TBL] [Abstract][Full Text] [Related]
35. LncRNA NOC2L-4.1 functions as a tumor oncogene in cervical cancer progression by regulating the miR-630/YAP1 pathway.
Wang Q; Ding J; Nan G; Lyu Y; Ni G
J Cell Biochem; 2019 Oct; 120(10):16913-16920. PubMed ID: 31099044
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis.
Rui X; Xu Y; Jiang X; Ye W; Huang Y; Jiang J
Cell Death Dis; 2018 Dec; 9(12):1175. PubMed ID: 30518760
[TBL] [Abstract][Full Text] [Related]
37. miR-424 acts as a tumor radiosensitizer by targeting aprataxin in cervical cancer.
Wang X; Li Q; Jin H; Zou H; Xia W; Dai N; Dai XY; Wang D; Xu CX; Qing Y
Oncotarget; 2016 Nov; 7(47):77508-77515. PubMed ID: 27769049
[TBL] [Abstract][Full Text] [Related]
38. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X
Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815
[TBL] [Abstract][Full Text] [Related]
39. miR-125b acts as anti-fibrotic therapeutic target through regulating Gli3 in vivo and in vitro.
Hu Z; Li L; Ran J; Chu G; Gao H; Guo L; Chen J
Ann Hepatol; 2019; 18(6):825-832. PubMed ID: 31548167
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression.
Hyun J; Wang S; Kim J; Rao KM; Park SY; Chung I; Ha CS; Kim SW; Yun YH; Jung Y
Nat Commun; 2016 Mar; 7():10993. PubMed ID: 27001906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
